The effect of therapy on subclinical atherosclerosis of the carotid arteries in patients with calcium pyrophosphate crystal deposition disease and osteoarthritis (pilot study)
Endothelial dysfunction associated with chronic microcrystalline inflammation plays a role in the progression of atherosclerosis in calcium pyrophosphate crystal deposition diseases (CPPD).The aim of the study was to assess the dynamics of the development of atherosclerosis based on changes in the t...
Saved in:
| Main Authors: | M. S. Eliseev, O. V. Zhelyabina, M. N. Chikina, E. I. Markelova, I. G. Kirillova, Yu. O. Korsakova, A. A. Kobriseva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2021-12-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/3105 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of colchicine, methotrexate, and hydroxychloroquine therapy on cardiovascular outcomes in patients with calcium pyrophosphate crystal deposition disease
by: M. S. Eliseev, et al.
Published: (2021-12-01) -
The prevalence of subclinical atherosclerosis of carotid arteries in patients with calcium pyrophosphate crystal deposition disease and osteoarthritis (pilot study)
by: M. S. Eliseev, et al.
Published: (2021-10-01) -
Experience with methotrexate in a patient with calcium pyrophosphate crystal deposition disease
by: E. V. Ilyinykh, et al.
Published: (2019-10-01) -
USE OF METHOTREXATE IN PATIENTS WITH CALCIUM PYROPHOSPHATE CRYSTAL DEPOSITION DISEASE
by: M. S. Eliseev, et al.
Published: (2018-05-01) -
Current strategy in the treatment of calcium pyrophosphate crystal deposition disease
by: S. A. Vladimirov, et al.
Published: (2019-01-01)